Glenn Lesser

Oncology

S Hawthorne Rd
Winston Salem, NC 27157

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 146 publications

Long-Term Fatigue After Treatment for Breast Cancer.

Long-Term Fatigue After Treatment for Breast Cancer.

Journal: JAMA network open

Published: August 18, 2026

Cancer-intrinsic SIRPα Signaling Triggers Mitochondrial Fission and Immune Tolerance to Promote TNBC Breast-to-Brain Metastasis.

Cancer-intrinsic SIRPα Signaling Triggers Mitochondrial Fission and Immune Tolerance to Promote TNBC Breast-to-Brain Metastasis.

Journal: Neuro-oncology

Published: February 25, 2026

Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment.

Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment.

Journal: Journal of adolescent and young adult oncology

Published: February 03, 2026

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD Caregiver Oncology Needs Evaluation Tool (CONNECT) trial.

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD Caregiver Oncology Needs Evaluation Tool (CONNECT) trial.

Journal: Contemporary clinical trials

Published: December 16, 2025

Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors.

Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors.

Journal: Neuro-oncology

Published: November 26, 2025

Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors.

Evaluating "brain permeability": A critical issue for the development of therapeutic agents for primary and metastatic brain tumors.

Journal: Neuro-oncology

Published: November 26, 2025

Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy.

Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy.

Journal: Science translational medicine

Published: October 29, 2025

Impact of an Electronic Patient-Reported Outcome-Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD).

Impact of an Electronic Patient-Reported Outcome-Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD).

Journal: JCO oncology practice

Published: October 21, 2025

Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity.

Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity.

Journal: JACC. CardioOncology

Published: October 15, 2025

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields.

Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields.

Journal: Oncotarget

Published: October 13, 2025

Examining recruitment differences by race, ethnicity, and age to a decentralized trial of an internet-delivered intervention for sexual health after breast cancer: the WF-2202 SHINE trial.

Examining recruitment differences by race, ethnicity, and age to a decentralized trial of an internet-delivered intervention for sexual health after breast cancer: the WF-2202 SHINE trial.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: September 25, 2025

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

Journal: Nature medicine

Published: August 29, 2025

Showing 1-12 of 146

Last Updated: 09/26/2026